M&A
Enzymaster’s Sanming Minhe Acquisition Increases Production Capacity by 50% to Keep Pace with Rapidly Growing Demand
Enzymaster
PR-M01-22-14Jan 20, 2022
The Future of Healthcare
The Future of Healthcare in the U.S. and the U.K.
Haig Armaghanian
Haig Barrett
PAO-04-22-R221-03Apr 07, 2021
Supply Chain
Nationalism and the Pharmaceutical Supply Chain
Haig Armaghanian
Haig Barrett
PAP-Q4-20-CL-012Dec 09, 2020
Trip Kickoff at Home House in Kensington, London
Nigel Walker
Nice Insight
PA1132Dec 09, 2020
It’s The End Of This Journey, But The Start Of The Next One
Nigel Walker
Nice Insight
PA1153Dec 09, 2020
Supply Chain Risk
The Precarious Pharmaceutical Supply Chain: To Reshore or Not to Reshore – Part 1
Haig Armaghanian
Haig Barrett
PAP-Q3-20-CL-020Sep 29, 2020
Brexit
Accelerated Innovation Is the Key to the UK’s Post-Brexit Life Sciences Leadership
Haig Armaghanian
Haig Barrett
PAP-Q1-20-CL-040Mar 19, 2020
Biosimilars
Is the U.S. Biosimilars Market Poised for Takeoff?
Haig Armaghanian
Haig Barrett
PAP-Q3-19-CL-015Oct 28, 2019
Oncology
Cancer’s New Foes—Novel Oncology Approaches in the Battle Against Cancer
Haig Armaghanian
Haig Barrett
PAP-Q2-2019-CL-020May 24, 2019
In Conversation
Behind the Scenes of International Pharmaceutical Business Success: A Conversation with Horst Wallrabe
Haig Armaghanian; Horst Wallrabe
Haig Barrett
PAO-M02-18-IC-001Feb 14, 2018
Mergers & Acquistions
Five Critical Considerations for Pharmaceutical M&A
Haig Armaghanian
Haig Barrett
PAO-M12-17-Cl-001Dec 07, 2017